Laboratoire de Bioimagerie et Pathologies


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2008

16 février 2012

M. ACHOUR, X. JACQ, P. RONDE, M. ALHOSIN, C. CHARLOT, T. CHATAIGNEAU, M. JEANBLANC, M. MACALUSO, A. GIORDANO, A.D. HUGHES, V.B. SCHINI-KERTH & C. BRONNER. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 27, 2187-2197, 2008 – IF 7.11

P. BARTIK, A. MAGLOTT, G. ENTLICHER, D. VESTWEBER, K. TAKEDA, S. MARTIN & M. DONTENWILL. Detection of a hypersialylated beta1 integrin endogenously expressed in the human astrocytoma cell line A172. Int. J. Oncol. 32, 1021-1031, 2008 – IF 2.39

P. BERNARD, C. DUFRESNE-FAVETTA, P. FAVETTA, Q.T. DO, F. HIMBERT, S. ZUBRZYCKI, T. SCIOR & C. LUGNIER. Application of drug repositioning strategy to TOFISOPAM. Curr. Med. Chem. 15, 3196-3203, 2008 – IF 4.96

J. BRUNET, A.W. PFAFF, A. ABIDI, M. UNOKI, Y. NAKAMURA, M. GUINARD, J.P. KLEIN, E. CANDOLFI & M. MOUSLI. Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell. Microbiol. 10, 908-920, 2008 – IF 5.43

M. CAMPOS-TOIMIL, T. KERAVIS, F. ORALLO, K. TAKEDA & C. LUGNIER. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca2+ responses in endothelial cells. Br. J. Pharmacol. 154, 82-92, 2008 – IF 4.71

M. CHAABI, C. ANTHEAUME, B. WENIGER, H. JUSTINIANO, C. LUGNIER & A. LOBSTEIN. Inhibition of human cAMP-phosphodiesterase as a mechanism of the spasmolytic effect of Matricaria recutita L. J. Agric. Food Chem. 56, 5015-5020, 2008 – IF 3.21

J.R. DE MEY, P. KESSLER, J. DOMPIERRE, F.P. CORDELIERES, A. DIETERLEN, J.L. VONESCH & J.B. SIBARITA. Fast 4D Microscopy. Method. Cell Biol. 85, 83-112, 2008 – IF 2.04

J.G. GOETZ, B. JOSHI, P. LAJOIE, S.S. STRUGNELL, T. SCUDAMORE, L.D. KOJIC & I.R. NABI. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin‑1. J. Cell Biol. 1­80, 1261-1275, 2008 – IF 10.12

Y. LANDRY & J.P. GIES. Drugs and their molecular targets : an updated overview. Fund. Clin. Pharmacol. 22, 1-18, 2008 – IF 2.15

I. LELONG-REBEL, C. BRISSON, M. FABRE, J.P. BERGERAT & G. REBEL. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Anticancer Res. 28, 55-68, 2008 – IF 1.51

M. MALCHER, D. VOLODKIN, B. HEURTAULT, P. ANDRE, P. SCHAAF, H. MÖHWALD, J.C. VOEGEL, A. SOKOLOWSKI, V. BALL, F. BOULMEDAIS & B. FRISCH. Embedded silver ions-containing liposomes in polyelectrolyte multilayers : cargos films for antibacterial agents. Langmuir 24, 10209-10215, 2008 – IF 4.56

M. OUEDRAOGO, S. LECAT, M. D. ROCHDI, M. HACHET-HAAS, H. MATTHES, H. GICQUIAUX, S. VERRIER, M. GAIRE, N. GLASSER, Y. MELY, K. TAKEDA, M. BOUVIER, J.L. GALZI & B. BUCHER. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization. Traffic 9, 305-324, 2008 – IF 5.47

P. RABOISSON, D. SCHULTZ, C. MULLER, J.M. REIMUND, G. PINNA, R. MATHIEU, P. BERNARD, Q.T. DO, R.L. DESJARLAIS, H. JUSTINIANO, C. LUGNIER & J.J. BOURGUIGNON. Cyclic nucleotide phosphodiesterase type 4 inhibitors : evaluation of pyrazolo [1,5-a]-1,3,5-triazine ring system as an adenine bioisostere. Eur. J. Med. Chem. 43, 816-829, 2008 – IF 3.36

Q. WANG, L. ELGHAZI, S. MARTIN, I. MARTINS, S. SRINIVASAN, X. GENG, M. SLEEMAN, P. COLLOMBAT, J. HOUGHTON & B. SOSA-PINEDA. Ghrelin is a novel target of Pax4 in endocrine progenitors of the pancreas and duodenum. Dev. Dynam. 237, 51-61, 2008 – IF 3.02